Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSofosbuvir/velpatasvir and glecaprevir/pibrentasvir: how should we choose among these two latest and probably the last regimens?PublicationHepatology Research, 2022, Vol 52, Issue 10, p815ISSN1386-6346Publication typeArticleDOI10.1111/hepr.13828